STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

被引：5
|
作者：
Zhang, Linlin [1 ]
Xiao, Ping [1 ]
Meng, Fanlu [1 ]
Zhong, Diansheng [1 ]
机构：
[1] Tianjin Med Univ, Gen Hosp, Dept Med Oncol, Tianjin 300052, Peoples R China
来源：
CURRENT ONCOLOGY | 2022年 / 29卷 / 10期
基金：
中国国家自然科学基金;
关键词：
STRN-ALK fusion; lung adenocarcinoma; brain metastasis; ensartinib;
D O I：
10.3390/curroncol29100530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion.
引用
收藏
页码：6749 / 6753
页数：5
相关论文
共 50 条
  • [21] Ciliated Muconodular Papillary Tumors of the Lung Harboring STRN::ALK Fusion: Case Report and Review of the Literature
    Zhang, Xinyi
    Yuan, Wei
    Luo, Rongkui
    Luan, Lijuan
    Huang, Jie
    Lu, Shaohua
    Sujie, Akesu
    Hou, Yingyong
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (07) : 1357 - 1363
  • [22] Novel PPFIA1-ALK, ALK-C2orf91(intergenic) double-fusion responded well to alectinib in an advanced lung adenocarcinoma patient: a case report
    Yan, Lingxin
    Zheng, Jiayu
    Pan, Qingyun
    Liang, Yuxian
    Yu, Pengli
    Chen, Quanfang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-ALK and ALK-EML4 in combined treatment of Alectinib and CyberKnife: A case report
    Li, Yumei
    Lu, Shijin
    Yao, Ping
    Huang, Wenchuang
    Huang, Yong
    Zhou, Ying
    Yuan, Ying
    Cheng, Shaochen
    Wu, Fasheng
    MEDICINE, 2024, 103 (03) : E36992
  • [24] Breast metastasis from EGFR/ALK negative lung adenocarcinoma A case report
    Cao, Liyu
    Lv, Liting
    MEDICINE, 2020, 99 (49) : E23503
  • [25] Ovarian Metastasis of ALK Translocation-Positive Lung Adenocarcinoma: A Case Report
    Gezer, Sener
    Cabuk, Devrim
    Aksoy, Lale
    Ozturk, Seda Duman
    Ozkara, Sevgiye Kacar
    Yucesoy, Izzet
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2020, 35 (04): : 475 - 478
  • [26] Pseudo-progression in a patient with lung adenocarcinoma and ALK fusion who responded to crizotinib
    Su, Chunxia
    Ren, Shengxiang
    Li, Xuefei
    Hou, Likun
    Zhou, Caicun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 12290 - 12293
  • [27] Salivary Intraductal Carcinoma Arising within Intraparotid Lymph Node: A Report of 4 Cases with Identification of a Novel STRN-ALK Fusion
    Lisa M. Rooper
    Lester D. R. Thompson
    Jeffrey Gagan
    Bahram R. Oliai
    Ilan Weinreb
    Justin A. Bishop
    Head and Neck Pathology, 2021, 15 : 179 - 185
  • [28] Pediatric lung adenocarcinoma presenting with brain metastasis: A case report
    De Martino L.
    Errico M.E.
    Ruotolo S.
    Cascone D.
    Chiaravalli S.
    Collini P.
    Ferrari A.
    Muto P.
    Cinalli G.
    Quaglietta L.
    Journal of Medical Case Reports, 12 (1)
  • [29] GefitinibCalcific miliary brain metastasis of the lung adenocarcinoma: case report
    Reactions Weekly, 2022, 1920 (1) : 235 - 235
  • [30] Acute renal injury induced by ensartinib in a lung adenocarcinoma patient treated with sequential ALK inhibitors: A case report and literature review
    Xie, Xinmiao
    Yang, Jing
    Chen, Fuhua
    Wang, Xiaoxia
    CLINICAL NEPHROLOGY, 2025, 103 (04) : 296 - 302
12345